Literature DB >> 2184061

Do angiotensin converting enzyme inhibitors represent a progress in hypertension care in diabetes mellitus?

P T Sawicki1, I Mühlhauser, T Baba, M Berger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2184061     DOI： 10.1007/bf00401052

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  44 in total

1.  Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study.

Authors:  J Wikstrand; I Warnold; G Olsson; J Tuomilehto; D Elmfeldt; G Berglund
Journal:  JAMA       Date:  1988-04-01       Impact factor: 56.272

2.  Problems of comprehensive shared diabetes care.

Authors:  J L Day; H Humphreys; H Alban-Davies
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-20

3.  Influence of diabetes mellitus on changes in left ventricular performance and renal function produced by converting enzyme inhibition in patients with severe chronic heart failure.

Authors:  M Packer; W H Lee; N Medina; M Yushak; P D Kessler; S S Gottlieb
Journal:  Am J Med       Date:  1987-06       Impact factor: 4.965

4.  Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients.

Authors:  T Pollare; H Lithell; I Selinus; C Berne
Journal:  BMJ       Date:  1989-04-29

5.  Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension.

Authors:  R Zatz; B R Dunn; T W Meyer; S Anderson; H G Rennke; B M Brenner
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

6.  Angiotensin converting enzyme inhibitors may cause renal impairment in diabetes mellitus.

Authors:  J Webster; L E Murchison; O J Robb
Journal:  Scott Med J       Date:  1988-04       Impact factor: 0.729

7.  The effects of antihypertensive therapy on the quality of life.

Authors:  S H Croog; S Levine; M A Testa; B Brown; C J Bulpitt; C D Jenkins; G L Klerman; G H Williams
Journal:  N Engl J Med       Date:  1986-06-26       Impact factor: 91.245

8.  [Lack of effect of ACE inhibition on severe proteinuria in diabetic nephropathy--a 6-month-long study].

Authors:  U Hay; B Ludvik; C Gisinger; G Schernthaner
Journal:  Schweiz Med Wochenschr       Date:  1988-02-06

9.  Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy.

Authors:  C E Mogensen
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-11

10.  1986 Guidelines for the treatment of mild hypertension: Memorandum from a WHO/ISH meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408
View more
  9 in total

1.  Enalapril and metoprolol in diabetic nephropathy.

Authors:  P Sawicki; L Heinemann; I Mühlhauser
Journal:  BMJ       Date:  1990-06-02

2.  Enalapril and metoprolol in diabetic nephropathy.

Authors: 
Journal:  BMJ       Date:  1990-05-26

Review 3.  To bridge science and patient care in diabetes.

Authors:  M Berger
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

4.  Do angiotensin converting enzyme inhibitors represent a progress in hypertension care in diabetes mellitus?

Authors:  K Rett; P T Sawicki
Journal:  Diabetologia       Date:  1991-02       Impact factor: 10.122

Review 5.  Recent Advances in Pharmacological Management of Hypertension in Diabetic Patients with Nephropathy : Effects of Antihypertensive Drugs on Kidney Function and Insulin Sensitivity.

Authors:  Tsuneharu Baba; Takashi Ishizaki
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

6.  Guidelines for management of hypertension. Metabolic effects of drug treatment exaggerated.

Authors:  P Sawicki
Journal:  BMJ       Date:  1994-03-26

7.  ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension.

Authors:  E Torlone; A M Rambotti; G Perriello; G Botta; F Santeusanio; P Brunetti; G B Bolli
Journal:  Diabetologia       Date:  1991-02       Impact factor: 10.122

8.  UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.

Authors: 
Journal:  Diabetologia       Date:  1991-12       Impact factor: 10.122

Review 9.  Renal long-term effects of calcium antagonist treatment in patients with diabetes mellitus.

Authors:  E Jungmann; K H Usadel
Journal:  Clin Investig       Date:  1992-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.